IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
iRhythm Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$109.60+0.94 (+0.87%)
Close on Oct 19, 2026
- Market cap
- $3.61B
- P/E (TTM)
- –
- Dividend yield
- –
iRhythm Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Contracted third-party payors | $392.23M | $311.61M | $267.20M | $223.98M | $193.87M | $135.94M | $101.85M | $56.95M | 52.5% | +25.9% |
| Centers for Medicare and Medicaid | $179.35M | $142.39M | $122.41M | $103.03M | $44.53M | $72.54M | $58.92M | $40.48M | 24.0% | +26.0% |
| Customer A | $125.61M | $95.12M | $71.00M | $59.77M | $57.50M | $41.40M | $43.02M | $37.40M | 16.8% | +32.1% |
| Non-contracted third-party payors | $49.94M | $42.73M | $32.07M | $24.13M | $26.93M | $15.30M | $10.77M | $12.45M | 6.7% | +16.9% |
By region
From the segment and revenue-disaggregation notes of iRhythm's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.